It takes a certain kind of courage to short sell blue chips, such as the Dow Jones industrial average components. Short sellers are betting on these companies to fail, or at least for their share prices to fall handily. Plus, those sellers are responsible for paying the dividends on the stocks they short.
Maybe it is little wonder that only three of the 30 Dow stocks had notable short interest between March 29 and April 15; that is, more than 50 million shares short. In fact, just six of them had short interest of more than 30 million shares.
Yet the bull market is quite long in the tooth — now more than 10 years old — and concern about a coming recession is rising. Investors may wonder then what the short sellers expect from some of the biggest, most well-respected names on Wall Street.
As of the April 15 settlement date, the most recently reported period, short sellers still favored Pfizer Inc. (NYSE: PFE), Apple Inc. (NASDAQ: AAPL) and Intel Corp. (NASDAQ: INTC) above all other Dow stocks.
> Shares short: 65.04 million
> Change from prior period: −18.6%
> Percentage of float: 1.2
This is the fourth double-digit percentage decline in a row, as short interest retreats after the almost 265% rise in early January to the greatest number of shares short at Pfizer so far this year. Another sharp drop may allow Apple to reclaim the top spot. And at the daily average volume on the most recent settlement date, it would take about four days for Pfizer short sellers to cover their positions.
Pfizer is among the 24/7 Wall St. recommended dividend stocks for retirees to own. By the end of the first two weeks of April, the share price had retreated less than 2%, while the Dow had gained less than 2% during the short interest period. The stock continued its pullback afterward.
Shares closed Thursday’s trading at $39.61 apiece, more than 1% higher than a week ago. Pfizer’s 52-week low of $34.37 was seen last spring, and the 52-week high of $46.47 was from this past December. The stock now is down about 9% since the beginning of the year.
> Shares short: 61.00 million
> Change from prior period: −10.0%
> Percentage of float: 1.3
Note that this was down from a year-to-date high of almost 97 million Apple shares short at the end of February and that the average daily trading volume dropped sharply during the first two weeks of this month. By the most recent settlement date, the number of days it would take for investors to cover all their short positions rose to more than two.
At least one analyst remained cautious on the stock during the period, anticipating further downside ahead. But short sellers watched the share price rise more than 6% yet then end the most recent settlement date with a gain of less than 5%. The Nasdaq saw a gain of almost 3% during those two weeks.
After increasing less than 1% in the past week, Apple stock ended trading most recently at $205.28 a share. That was in a 52-week range of $142.00 (at the beginning of this year) to $233.47 (last October). The share price currently is about 30% higher year to date.
> Shares short: 52.10 million
> Change from prior period: −3.4%
> Percentage of float: 1.2
This was on top of a more than 5% decline in the previous period and now is the lowest short interest in at least a year. Note that the average daily trading volume also fell to a 52-week low, and as of the middle of this month, it would take more than three days for investors to cover all their short positions.